Form 4: Kindly MD CIO Granted 601,503 Restricted Stock Units

Sentiment:

Insider Transaction Report


Kindly MD's Chief Investment Officer, Tyler Matthew Evans, was granted 601,503 restricted stock units with a four-year vesting schedule.

Summary

  • Tyler Matthew Evans, Chief Investment Officer of Kindly MD, Inc. (NAKA), acquired 601,503 shares of Common Stock.
  • The acquisition occurred on September 22, 2025, and represents Restricted Stock Units (RSUs).
  • These RSUs have a four-year time-vesting period.
  • There will be no vesting during the first twelve months following August 15, 2025 (the 'Cliff Period').
  • Twenty-five percent (25%) of the RSUs will vest upon completion of the Cliff Period.
  • The remaining seventy-five percent (75%) of the RSUs will vest in equal quarterly installments over the subsequent thirty-six months.
  • Vesting is contingent upon Mr. Evans' continued service to Kindly MD through each applicable vesting date.
  • Following this transaction, Mr. Evans beneficially owns a total of 3,012,188 shares of Common Stock.

Sentiment

Score: 7

Explanation: The RSU grant is a positive development for aligning management incentives with shareholder interests and executive retention, which is generally viewed favorably. It is a routine compensation event, not indicative of extraordinary financial performance, hence a moderately positive score.

Positives

  • The grant of Restricted Stock Units (RSUs) aligns the Chief Investment Officer's long-term interests with those of the shareholders, incentivizing sustained performance.
  • The four-year vesting schedule, including a one-year cliff, promotes executive retention and commitment to the company's long-term strategic goals.

Negatives

  • The future vesting of these RSUs will result in dilution for existing shareholders as new shares are issued.

Risks

  • The vesting of the RSUs is subject to the reporting person's continued service to the issuer through each applicable vesting date, meaning the shares could be forfeited if employment ceases.

Future Outlook

The RSU grant with a four-year vesting schedule indicates a long-term incentive structure designed to retain the Chief Investment Officer and align his performance with the company's future success over this period.

Management Comments

  • RSUs shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the 'Cliff Period').
  • Thereafter, twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty-six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date.

Industry Context

The grant of Restricted Stock Units (RSUs) is a common practice in the U.S. public markets for executive compensation. It serves as a key mechanism to attract, retain, and motivate senior management by providing them with an equity stake in the company, thereby aligning their financial interests with those of shareholders. This type of compensation is particularly prevalent in growth-oriented companies.

Comparison to Industry Standards

  • The four-year vesting period with a one-year cliff is a standard structure for RSU grants in many industries, including healthcare and technology, aiming to ensure long-term commitment from executives.
  • The grant size for a Chief Investment Officer role is generally commensurate with the company's market capitalization and the executive's responsibilities, though specific comparisons require detailed peer group analysis not provided in this filing.

Stakeholder Impact

  • Shareholders: Potential future dilution from the issuance of new shares upon vesting, but also benefit from increased alignment of management's interests with long-term company performance.
  • Employees: The RSU grant to a key executive may signal stability and a commitment to long-term growth, potentially boosting morale.

Next Steps

  • Tyler Matthew Evans must continue his service to Kindly MD, Inc. to fulfill the vesting conditions for the RSUs.
  • The first vesting event for 25% of the RSUs will occur after the 12-month Cliff Period following August 15, 2025.
  • Subsequent vesting events will occur in equal quarterly installments over the 36 months following the initial 25% vesting.

Key Dates

DateDescription
08/15/2025Start date for the 12-month 'Cliff Period' for RSU vesting.
09/22/2025Date of the RSU transaction.
09/24/2025Date the Form 4 was signed.

Keywords

Kindly MD, NAKA, Restricted Stock Units, RSUs, Insider Transaction, Executive Compensation, Tyler Matthew Evans, Chief Investment Officer, Stock Grant, Vesting Schedule

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.